Patents by Inventor Yong Wei Piao

Yong Wei Piao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12268728
    Abstract: Provided are a recombinant hyaluronan and proteoglycan link protein 1 (HAPLN1), and a composition for preventing or treating pulmonary diseases, the composition comprising at least one selected from the group consisting of HAPLN1 (hyaluronan and proteoglycan link protein 1) protein, a gene coding for the HAPLN1 protein, and an effective agent for promoting the expression or activating the functions of HAPLN1 protein or gene as an active ingredient. The recombinant HAPLN1 according to the present disclosure may have superior effects of improving alveolar damage caused by aging or elastin reduction, and thus may effectively prevent or treat pulmonary diseases, such as chronic bronchitis, asthma, emphysema, and chronic obstructive pulmonary disease.
    Type: Grant
    Filed: February 2, 2021
    Date of Patent: April 8, 2025
    Assignee: HAPLNSCIENCE, INC.
    Inventors: Dae Kyong Kim, Yong Wei Piao, Ji Min Jang, Dan Zhou, So Yoon Yun, Bo Kyung Park
  • Publication number: 20240350583
    Abstract: Disclosed in the present invention are: a pharmaceutical composition for preventing or treating fibrotic diseases, comprising hyaluronan and proteoglycan link protein 1 (HAPLN1) or a gene encoding same as an active ingredient; and a method for preventing or treating fibrotic diseases using the composition. According to the present invention, fibrosis of cells or tissues is prevented and inhibited such that the occurrence or progression of various kinds of diseases caused by fibrosis is fundamentally suppressed, and thus the diseases can be prevented or treated.
    Type: Application
    Filed: August 2, 2022
    Publication date: October 24, 2024
    Applicants: Chung Ang University Industry Academic Cooperation Foundation, Haplnscience Inc.
    Inventors: Dae Kyong Kim, Yong Soon Kim, Moon Jung Back, Jung Hoon Pyo, David Kim, Yong Wei Piao, Min A Yeom
  • Publication number: 20220305077
    Abstract: Provided are a recombinant hyaluronan and proteoglycan link protein 1 (HAPLN1), and a composition for preventing or treating pulmonary diseases, the composition comprising at least one selected from the group consisting of HAPLN1 (hyaluronan and proteoglycan link protein 1) protein, a gene coding for the HAPLN1 protein, and an effective agent for promoting the expression or activating the functions of HAPLN1 protein or gene as an active ingredient. The recombinant HAPLN1 according to the present disclosure may have superior effects of improving alveolar damage caused by aging or elastin reduction, and thus may effectively prevent or treat pulmonary diseases, such as chronic bronchitis, asthma, emphysema, and chronic obstructive pulmonary disease.
    Type: Application
    Filed: February 2, 2021
    Publication date: September 29, 2022
    Applicant: HAPLNSCIENCE INC.
    Inventors: Dae Kyong Kim, Yong Wei Piao, Ji Min Jang, Dan Zhou, So Yoon Yun, Bo Kyung Park